Molbio Diagnostics

Molbio Diagnostics, founded in 2000, became a unicorn in September 2022 with a $1.6 billion valuation. The company has raised $124 million to date from investors including Temasek and Motilal Oswal Private Equity. Headquartered in Salcete, Goa, India, Molbio Diagnostics provides point-of-care molecular diagnostic solutions including cartridge-based sample prep, portable x-ray systems, AI thermal scanning, and real-time PCR analyzers. Serving hospitals and laboratories, the platform enables rapid, accurate infectious disease detection. With strong funding and innovative diagnostics, Molbio Diagnostics is positioned to scale healthcare access and molecular testing worldwide.